Suppr超能文献

液相色谱-质谱联用技术在体外药物代谢物筛选中的应用

Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.

作者信息

Tolonen Ari, Turpeinen Miia, Pelkonen Olavi

机构信息

Novamass Ltd., Medipolis Center, Kiviharjuntie 11, 90220 Oulu, Finland.

出版信息

Drug Discov Today. 2009 Feb;14(3-4):120-33. doi: 10.1016/j.drudis.2008.11.002. Epub 2008 Dec 26.

Abstract

A combination of high performance liquid chromatography (HPLC) and mass spectrometry (LC/MS) has proven its status as the most powerful analytical tool for screening and identifying drug metabolites in modern drug discovery. These techniques have become irreplaceable for drug metabolism laboratories, providing high amounts of information from a wide variety of samples. This review focuses on the most common and useful applications of these techniques when working on in vitro metabolism, more specifically with screening and identification of chemically stable or reactive metabolites formed via biotransformation reactions. Matching specific tasks and suitable instruments is a recurring consideration; for many reasons, the time-of-flight or orbitrap mass spectrometry provides clearly increased efficiency in metabolite profiling compared to other types of mass spectrometry.

摘要

高效液相色谱(HPLC)与质谱(LC/MS)联用已证明其作为现代药物研发中筛选和鉴定药物代谢物最强大分析工具的地位。这些技术已成为药物代谢实验室不可或缺的手段,能从各种样品中提供大量信息。本综述聚焦于这些技术在体外代谢研究中的最常见且有用的应用,更具体地说是用于筛选和鉴定通过生物转化反应形成的化学稳定或具反应性的代谢物。匹配特定任务和合适仪器是一个反复需要考虑的问题;出于多种原因,飞行时间质谱或轨道阱质谱在代谢物谱分析方面比其他类型的质谱效率明显更高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验